on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has submitted a Form 8.3 to the Irish Takeover Panel. This document pertains to Mural Oncology plc, revealing Vanguard's position regarding the company's securities. As of June 27, 2025, Vanguard holds 772,851 ordinary shares, accounting for 4.48% of Mural Oncology's shares.
The disclosure includes a sale of 64 shares at a price of 2.48 USD each. No cash-settled or stock-settled derivative transactions have been reported. Additionally, there are no indemnities, agreements, or understandings influencing securities dealing or voting rights. Vanguard confirmed no supplemental Form 8 was necessary.
This form ensures compliance with Rule 8.3 of the Irish Takeover Panel Act, 1997, concerning stakeholders with significant interest or positions in relevant securities.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news